O’Connor, O. 2009. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in heavily pretreated patients with hematological malignancies. Hematology Meeting Reports (formerly Haematologica Reports). 1, 8 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v1i8.297.